Traumatic brain injury future or investigational therapies

Traumatic brain injury Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Traumatic Brain Injury from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Neurocognitive Disorder due to Traumatic Brain Injury
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Traumatic brain injury future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Traumatic brain injury future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Traumatic brain injury future or investigational therapies
CDC on Traumatic brain injury future or investigational therapies
Traumatic brain injury future or investigational therapies in the news
Blogs on Traumatic brain injury future or investigational therapies
Directions to Hospitals Treating Traumatic brain injury
Risk calculators and risk factors for Traumatic brain injury future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Joanna Ekabua, M.D. [2]

Overview

In spite of robust experiments on the efficacy of neuroprotective drugs tested in animal models of traumatic brain injury, all Phase III clinical trials of neuroprotection have failed in patients with traumatic brain injury.

References

Template:WikiDoc Sources